Consumer Discretionary · Wholesale-Lumber & Other Construction Materials

ASPN ASPEN AEROGELS INC SEC Filings & Insider Trading Activity 2026

company
CIK 114598698 filings
Russell 2000

ASPN at a glance

ASPEN AEROGELS INC (ASPN, SEC CIK 1145986) filed its latest 10-K annual report on March 13, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as November 6, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), ASPEN AEROGELS INC (ASPN) reported revenue of $271.1 million (down 40.1% from FY2024) and a net loss of $389.6 million. Diluted EPS was -$4.73.
  • As of September 30, 2026, 27 institutional investment managers tracked by SignalX reported holding ASPEN AEROGELS INC (ASPN) shares worth $149.6 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Wood River Capital, LLC on September 23, 2026 of 12,280,426 shares at $4.73 per share.
  • In the last 90 days, ASPN insiders reported 0 open-market purchases ($0) and 1 open-market sale ($58.1M) on Form 4, a net sale of $58.1M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$271.1M
−40.1% vs prior year
Insiders · 90 days
0 buys · 1 sell
Net −$58.1M
13F holders
27 funds
$149.6M · −2 vs prior quarter
Latest 8-K
Nov 5, 2026
Item 2.02 · Item 5.02 · Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material risk-factor changes since the Annual Report, except disclosures in the March 31, 2026 Form 10-Q
  • Carried-forward risks remain governed by the Annual Report’s Part I, Item 1A disclosures
  • No new regulatory, operational, competitive, or financial risks identified in this filing

Management Discussion & Analysis

  • Revenue $85.2M, up 17% YoY from $73.0M, driven by Energy Industrial growth
  • Gross margin 24% vs 28% YoY, with net loss $10.4M vs $6.3M
  • Best segment Energy Industrial: revenue $39.9M, up 64%; gross margin 39% vs 36%
  • Worst segment Thermal Barrier: revenue $45.3M, down 7%; gross margin 11% vs 24%
  • Cash $146.0M, operating cash flow $14.2M; $27.3M financing outflow, including $19.5M term-loan repayment

AI summary of the ASPN 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results announced for quarter ended September 30, 2026
  • Business developments included in accompanying Exhibit 99.1 press release

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Stacy D. Nieuwoudt appointed independent Class III director effective November 4, 2026, expanding the Board from six to seven members
  • Added to Audit and Compensation & Leadership Development Committees, strengthening energy-sector and capital-markets expertise

Item 7.01: Regulation FD Disclosure

  • Item 7.01 incorporates Aspen Aerogels’ press-release financial outlook into the company’s public disclosure
  • Investors should review the referenced “Financial Outlook” section for management’s current expectations and market guidance

Item EX-99.2: Item EX-99.2

  • Stacy Nieuwoudt appointed director effective November 4, 2026
  • Board adds energy-sector and asset-management expertise from Citadel-affiliated firms

Item EX-99.1: Item EX-99.1

  • Q3 revenue $85.2M, up 17% YoY and 71% QoQ, led by Energy Industrial revenue growth to $39.9M
  • Adjusted EBITDA $19.8M, or 23% margin, versus $6.3M and 9% YoY, despite $15.1M East Providence incident costs
Filed Sep 15, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Aspen Aerogels posted an investor presentation on September 15, 2026, for use in investor and analyst discussions
  • Presentation contents represent management’s investor messaging and outlook; investors should review Exhibit 99.1 for substantive details
Filed Aug 6, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Item 7.01 incorporates the press release’s “Financial Outlook” and company description into the disclosure record
  • Investors should review the referenced exhibit for Aspen Aerogels’ latest outlook and operating expectations

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 results announced for quarter ended June 30, 2026
  • Business developments discussed alongside quarterly financial results

Item EX-99.1: Item EX-99.1

  • Q2 revenue $49.8M, down from $78.0M, with Thermal Barrier revenue $29.5M, down 47% year over year
  • Adjusted EBITDA $(6.6)M versus $9.7M, reflecting $5.3M of East Providence incident-related costs

AI summaries of ASPN 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ASPN

Don't miss the next ASPN filing

  • Alerts as it files. A push when ASPN files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ASPN, by share count.
  • Ask anything. An AI agent that reads every ASPN filing and answers with sources.

ASPN alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Nieuwoudt Stacy DurbinANov 4, 2026-
Nieuwoudt Stacy DurbinANov 4, 2026-
DEEGAN GLENN E.FSep 30, 2026$5.48
Wood River Capital, LLCSellSep 23, 2026$4.73
NOGLOWS WILLIAM PMJun 23, 2026-
NOGLOWS WILLIAM PMJun 23, 2026$4.75
Mitchell Steven RAMay 13, 2026-
NOGLOWS WILLIAM PAMay 13, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$452.7M$271.1M
Gross Profit-$182.9M$46.0M
Operating Income-$54.5M-$378.2M
Net Income-$13.4M-$389.6M
Gross Margin-40.4%17.0%
Op. Margin-12.0%-139.5%
Net Margin-3.0%-143.7%
Balance Sheet
Total Assets$703.0M$895.1M$406.7M
Equity-$614.7M$235.5M
ROE-2.2%-165.4%
Per Share
EPS-$0.17$-4.73
Cash Flow
Operating CF-$45.5M$32.9M
CapEx$175.5M$86.3M$37.4M

Source: XBRL data in ASPEN AEROGELS INC (ASPN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate ASPN share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ASPN shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202627$149.6M
Q2 202629$166.4M
Q1 202627$80.2M
Q4 202524$79.2M
Q3 202525$180.6M
Q2 202526$143.6M
Q1 202524$121.8M
Q4 202417$184.0M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
None this quarter.
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 199 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ASPN filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 6, 2026--
10-QNov 5, 2026Analysis
8-KNov 5, 2026Analysis-
4Oct 1, 2026--
4Sep 24, 2026--
8-KSep 15, 2026Analysis-
10-QAug 7, 2026Analysis
8-KAug 6, 2026Analysis-
4Jun 26, 2026--
8-KMay 18, 2026Analysis
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
10-QMay 8, 2026Analysis
8-KMay 7, 2026Analysis
8-KApr 21, 2026Analysis-
10-KMar 13, 2026-
4Mar 10, 2026--
4Mar 10, 2026--
4Mar 10, 2026--
4Mar 10, 2026--
4Mar 6, 2026--
4Mar 6, 2026--

Related Consumer Discretionary companies

All Consumer Discretionary →

ASPN SEC filings: frequently asked questions

Are ASPN insiders buying or selling?

In the last 90 days, ASPEN AEROGELS INC (ASPN) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $58.1 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold ASPN stock?

As of September 30, 2026, the largest ASPEN AEROGELS INC (ASPN) holders among the 13F filers tracked by SignalX were BlackRock ($29.1 million), Vanguard Capital Management LLC ($19.4 million), State Street Corp ($14.0 million), Dimensional Fund Advisors ($11.2 million), AQR Capital Management ($10.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ASPN's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), ASPEN AEROGELS INC (ASPN) reported revenue of $271.1 million (down 40.1% from FY2024) and a net loss of $389.6 million. Diluted EPS was -$4.73. The figures come from the XBRL data in the 10-K.

What did ASPN report in its latest 8-K?

ASPEN AEROGELS INC (ASPN) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Appointment of Directors or Principal Officers) and Item 7.01 (Regulation FD Disclosure). Q3 2026 results announced for quarter ended September 30, 2026.

What are the latest ASPN SEC filings?

ASPEN AEROGELS INC (ASPN) filed its latest 10-K annual report on March 13, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on November 6, 2026.

What is ASPN's SEC CIK number?

ASPEN AEROGELS INC (ASPN)'s SEC Central Index Key (CIK) is 1145986. EDGAR lists every ASPN filing under that number.

Ask anything about ASPN

The research agent reads ASPN's filings, financials, insider trades and 13F holders, then answers with sources.